Outlook Therapeutics, Inc.
OTLK
Revenue
5.85M
▲5.27M▲902.58%
3 Months ChangeAssets
17.01M
▼-11.82M▼-41.00%
3 Months ChangeLiabilities
67.30M
▼-34.60M▼-33.96%
3 Months ChangeFree Cash Flow
-10.02M
▼-271.59k▼-2.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0001558370-24-012234
2024-08-14
Form 8-K
ID: 0001104659-24-089325
2024-07-08
Form 8-K
ID: 0001104659-24-078207
2024-05-28
Form 8-K
ID: 0001104659-24-065609
2024-05-15
Form 8-K
ID: 0001104659-24-062054
2024-05-15
Form 10-Q
ID: 0001558370-24-008318
2024-05-13
Form 8-K
ID: 0001104659-24-060517
2024-05-01
Form 8-K
ID: 0001104659-24-055141
2024-04-15
Form 8-K
ID: 0001104659-24-047322
2024-04-12
Form 8-K
ID: 0001104659-24-046752